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ABSTRACT 
Objective: Develop a simple isocratic reverse phase high performance liquid chromatographic method (RP-HPLC) and validate for the 
determination of lincomycin hydrochloride (LMH) in bulk and pharmaceutical preparations. 
Methods: RP-HPLC quantification was carried out by using fine pack SIL RPC18 
Results: The retention time of the drug was 3.73 min and produced at a linear response in the concentration range of 5-25µg/ml. The percentage 
RSD was found to be below 2%. The LOD and LOQ were found to be 0.854µg/ml and 0.258µg/ml respectively.  
column. The mobile phase (methanol: water) was pumped at a flow 
rate of 1 ml/min in the ratio of 90:10 v/v and the eluents were monitored at 254 nm. 
Conclusion: Validation of the method was performed for precision, accuracy, linearity, ruggedness, specificity and sensitivity to conform to ICH 
guidelines for valuation for analytical methods. 
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Lincomycin hydrochloride (LMH) broadly used as a systemic 
antibiotic, belongs to the collection of lincosamide, which is effective 
against maximum common gram-positive bacteria. Lincomycin 
hydrochloride prevents cell growth and microbial protein synthesis, 
by interacting powerfully and precisely with the 50S ribosomal 
subunit, at mutually related sites (fig. 1) [1]. Chemically LMH is a 
methyl 6-amino-6,8–dideoxy-N-[(2S,4R)-1-methyl-4-propylprolyl]-
1-thio-D-erythro-α-D-galacto-octopyranoside hydrochloride 
monohydrate, antimicrobial bodies produced by Streptomyces 
lincolnensis var. lincolnensis or by some other means[2,3]. It is 
approved in Indian pharmacopoeia [4, 5], British pharmacopoeia [6], 
the United States of pharmacopoeia and National formulary [7]. A 
few analytical method have been stated for its quantitative 
determination in pharmaceutical formulations like GC [4-7] liquid 
chromatography with pulsed electrochemical detection [8], UV 
spectrophotometry [9], colorimetry [10], and atomic absorption 
spectroscopy [11]. In view of the above fact, specific fast and 
sensitive analytical methods are in need for its quantitative 
determination. 
The purpose of the study was to improve a simple, precise, rapid and 
accurate reverse phase HPLC method for the estimation of 















Fig. 1: Molecular structure of lincomycin hydrochloride  
MATERIALS AND METHODS 
Reagents and chemicals  
Analytically pure lincomycin hydrochloride was attained as gift sample 
from Wallace Pharmaceuticals Pvt Ltd, Goa, India. Methanol and water 
of HPLC grade obtained from Hi-media chemicals, Mumbai were used 
for the preparation of mobile phase. As this drug has no marketed 
tablet preparations yet, we have formulated the tablets by changing 
the ratio of polymers by most usually used excipients by keeping the 
strength as constant (750 mg of LMH) and estimated the drug. 
Instruments used  
An isocratic high pressure liquid chromatographic system consisted 
of the following components: HPLC equipment (Jasco, Japan) 
consists of model PU-2080 HPLC pumps, UV-2075 model UV/Visible 
detector and AS-1559 model sampler. Chromatographic analysis 
was performed using the chrompass software on reverse phase fine 
park SIL C18
Preparation of mobile phase and stock solutions 
 T-5 column with 250 x 4.6 mm i. d and particle size 
5μm. 
The mobile phase consisting of methanol: water (90:10) v/v was 
selected. The solution was sonicated for 5 min. 750 mg of lincomycin 
hydrochloride raw material was weighed and transferred to 100 ml 
volumetric flask and dissolved in HPLC water to give 1000 μg/ml of 
LMH. Lincomycin hydrochloride solutions were further diluted with 
mobile phase to obtain a final concentration of 100μg/ml. 
Chromatographic conditions 
Ideal composition of mobile phase comprising of methanol: water 
(90:10) v/v was selected as it was found to preferably resolve the 
peaks of lincomycin hydrochloride. Reverse phase C18 column 
equilibrated with mobile phase was used. Mobile phase was filtered 
before procedure through 0.45 µm membrane filter and then 
ultrasonicated. The flow rate was sustained at 1 ml/min and effluents 
were monitored at 254 nm. The sample was introduced by using a 
20μl fixed loop and the total run time was 5 min. All determinations 
were done at constant column temperature (30 °C). The retention time 
for lincomycin hydrochloride under the improved chromatographic 
conditions was found to be 3.73 min (fig. 2). 
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Linearity of data 
Suitable aliquots of lincomycin hydrochloride stock solutions were 
pipetted into different 10 ml standard flasks and made up to the 
mark with mobile phase to attain a final concentration of 
5,10,15,20,25 μg/ml respectively. Triplicate dilutions of all 
concentration were introduced into the HPLC in duplicate. The 
linearity of calibration graphs and obedience of the system to beer’s 
law was confirmed by the high significance of correlation coefficient. 
Solutions were injected using a 20μL fixed loop system and 
chromatograms were noted. Calibration curves were made by 
plotting area versus concentration and regression equation was 
calculated for lincomycin hydrochloride. 
Assay of formulations 
Twenty tablets comprising 750 mg of LMH were weighed and finely 
powdered. An exactly weighed powder sample equivalent to 100 mg of 
LMH was dissolved in HPLC water. The above solution was sonicated for 
30 min and then filtered over a 0.45 μm membrane filter. An appropriate 
aliquot of this solution was pipetted into 100 ml standard flask, and the 
solution was finally made up to the mark with mobile phase. From the 
above solution, two concentrations were introduced and 
chromatograms were noted and matched with the standard.  
Validation of HPLC method 
The proposed HPLC method was confirmed as per ICH guidelines [12-15]. 
The precision of the method was analysed by performing recovery 
studies at 25, 50 and 75 % of the test concentrations. The precision 
of the method was validated by interday and intraday studies. To 
calculate the robustness of the established RP-HPLC method, small 
deliberate deviations in the optimized method parameters like the 
effect of a change in flow rate, mobile phase ratio and column 
temperature on the retention time, tailing factor, area count and 
percentage content of LMH were studied. The results of validation 
and system suitability studies are given in table 2. 
RESULTS AND DISCUSSION 
Method validation 
Linearity 
The linearity of lincomycin hydrochloride employing RP-HPLC 
method was constructed by plotting area of lincomycin 
hydrochloride against concentration. The recommended method was 
found to be modest and true in the concentration range of 5-25 μg/ml 
for lincomycin hydrochloride. It was established to be true with a 
correlation coefficient of 0.9998 and the data is shown table 1.  
Limit of detection (LOD) and limit of quantification (LOQ) 
LOD is calculated by using the formula 3.3 times σ/s where “σ” is the 
standard deviation of intercept and “s” is the slope obtained for 
calibration curve and limit of quantification was found to be 
0.854µg/ml and 0.258µg/ml, respectively. Similarly, LOQ is 
calculated by using the formula 10 times σ/s. The data are depicted 
in table 1. 
Precision 
This method was confirmed for its intra studies, the relative 
standard deviation, based on the peak area for six triplicate 
injections of standard preparations of LMH. The % RSD was found to 
be 0.229. 
Intermediate precision 
The analytical method was determined by performing method 
precision on the three successive days by different analyst under 
same experimental condition by injecting six replicate standard 
solutions of LMH. The %RSD was found to be 0.352. Intra and 
interday correctness were found to be less than 2% presenting high 
precision of the assay method. 
Accuracy 
It was also detected that that there was a significant recovery of LMH 
when a known amount of the drug was added to a crushed sample of 
the tablet dosage form. The mean percent recovery was 99.8%. The 
proposed HPLC method can be used for the determination of LMH in 
tablet dosage forms. Also, the % RSD for both the tablet analysis and 
recovery studies were less than 2% signifying a high degree of 
precision and accuracy of the suggested method. The estimated 
amount and percentage label claim are given in table 2. 
Ruggedness 
The ruggedness of the method for LMH was calculated with six 
injections by using two different coloumns. The % CV of ruggedness 
for LMH was 0.24 with coloumn-1 and 0.07 with colomn-2, which is 
within acceptable limits (table 1) 
  
Table 2: Analysis of tablet formulation and recovery studies 






Mean % recovery# 
Tablet 1 744.87 99.3 0.2651 0.5017 0.2041 99.57 
Tablet 2 749.91 99.9 0.5718 0.6609 0.1952 99.73 
*Denotes average of six determinations, #
 
Denotes average of three determinations at each level of recovery. 
Table 1: Validation parameters determination during method validation for the detection and quantification of lincomycin hydrochloride 
Validation parameter* Lincomycin hydrochloride 
Linearity range (µg/ml)  5-25 µg/ml 
Coefficient of correlation(r2 0.99986 )  
LOD(µg/ml)(±%RSD) 0.258 
LOQ (µg/ml) (±%RSD) 0.854 
Retention time (min.) 3.73 
Accuracy (%) 99.6±0.82 





Tailing factor 1.2 
Recovery (%) (±%RSD) 99.8 







Repeatability (RSD*,n = 6) 0.14 
*The validation parameters were determined from the analysis of eight standard solutions (n=6), %RSD: Percentage relative standard deviation. (% 
CV): coefficient of variation. LOD: Limit of detection, LOD: Limit of quantification.  
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The outcomes of robustness reading as 0.04 also showed that the 
method is robust and is unaffected by minor differences in the 
chromatographic conditions. 
System suitability 
The developed method was validated according to regulatory guidelines 
[16-19]. Results of validation and system suitability testing are summed 
up in table 1. The results complied with the acceptance criteria laid down 
under regulatory guidelines [20] with % RSD values, tailing factor, 
asymmetry factor and height equivalent to theoretical plates being well 
below the acceptable limits and correlation coefficient, and a number of 
theoretical plates were above the minimum acceptance criterion.  
System suitability parameters such as capacity factor, tailing factor and 
number of theoretical plates was found to be 2.8, 1.2, 4025, respectively. 
The retention time of lincomycin hydrochloride was found to be 3.73 
min and depicted in fig. 1. 
 
 
Fig. 1: A typical chromatogram of LMH (3.73 min) in tablet formulation 
 
CONCLUSION 
In the present study, LMH is determined by RP-HPLC, good linearity 
obtained for the drugs 5-25 µg/ml with a regression coefficient of 
0.9998. The results for precision, recovery and ruggedness were within 
the limits. Hence, the established RP-HPLC method is simple, correct, 
precise and robust and can be employed effectively for the routine 
anlaysis of LMH in bulk and pharmaceutical dosage preparations. 
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